Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PHAR | Amsterdam | EUR | Real-time | |
PHARMa | BATS Europe | EUR | Delayed | |
PHAR | NASDAQ | USD | Real-time | |
PHGN | Frankfurt | EUR | Delayed |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 81.2 | 66.7 | 54.9 | 42.54 |
Gross Profit | 74.1 | 58.4 | 49.17 | 38.47 |
Operating Income | 1.1 | 1.9 | -15.78 | -13.66 |
Net Income | -2.7 | 3.5 | 1.32 | -12.21 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 461.42 | 436.47 | 429.8 | 423 |
Total Liabilities | 242.24 | 226.52 | 229.43 | 223.65 |
Total Equity | 219.19 | 209.94 | 200.37 | 199.34 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 11.36 | 3.53 | -9.62 | -22.78 |
Cash From Investing Activities | -3.91 | -145.57 | 20.31 | -0.215 |
Cash From Financing Activities | -1.02 | 5.24 | -2.63 | -2.63 |
Net Change in Cash | 6.87 | -137.72 | 7.59 | -22.56 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review